Finasteride reduces the risk of prostate cancer

A new study published last week showed that the drug finasteride, which is used in the treatment of urinary tract disease, is likely to significantly reduce the risk of prostate cancer in men.

According to the research results of experts from the National Cancer Institute (USA), the use of drugs for treating urinary tract finasteride can reduce the risk of prostate cancer in men by up to 30%, At the same time, it does not promote the growth of tumors and does not increase the risk of death of patients.

A group of scientists led by Dr Ian Thompson, a cancer treatment specialist, has been conducting research for more than 18,000 men aged 55 and older using finasteride. Results showed that only about 10% of people using finasteride had prostate cancer, while the rate of non-drug users was 15%.

Dr. Michael LeFevre, a member of the research team, said the use of finasteride to treat urinary tract disease in men is perfectly suited and does not cause serious side effects. However, according to him, people using this drug may fall into a state of fatigue, even depression and significantly reduce sexual desire. So men need to consider carefully before deciding to use this medicine.

In the US, about 240,000 people are diagnosed with prostate cancer each year, of which about 30,000 die. The results of this study may bring new perspectives on the use of anticancer drugs.